Ally Biotech with Chef Francis Baczek

Ally Biotech with Vice President of Business Development Chef Francis Baczek today on Blunt Business only on The Cannabis Radio. Our next guest’s company brings next-generation oral delivery technologies to the cannabinoid market, empowering brands to become industry game-changers. Ally Biotech offers product development services and manufacturing-ready, water-soluble Lipofusion™ THC that can be utilized as a raw ingredient in powder or liquid form in a variety of products. There are manufacturing methods used like liposomal technology and bio-mimicking processes that create a more natural pathway in the body for improving absorption. With liposomal technology, safety is more defined than nanotechnology. Nanotechnology fractures the compounds into tiny (nanometer-sized) particles, with the goal of the compounds’ being so small they enter the bloodstream without degradation in the liver. The issue with nano-technology is understanding the pharmacokinetics of the nano-particles and how they truly absorb, distribute, metabolize and excrete (ADME) in the body. We talk about the Lipofusion™ delivery technology.

Ally

It combines nanotechnology and liposomal science to speed product differentiation and innovation. Lipofusion™ incorporates soluble fibers with nanoliposome vesicles to mitigate bioactive degradation and overcome common obstacles to bioavailability. Help me wrap my head around the difference between this nanotechnology and other similar methods. More from the Why and How to piece I talked about before the break: Bioavailability of cannabinoids has improved significantly over the last decade with the advent of Nano-emulsion technology. However, degrees of efficacy vary based on the methods used to deliver cannabinoids such as Cannabidiol (CBD). The most interesting and beneficial innovation of our patent-pending Lipofusion™ technology is that our vesicles utilize a nanoliposomal encapsulation process to encase CBD actives within phospholipids that are bio-identical to the membranes that surround human cells. This allows the nanoliposomes to easily target cells on a molecular level, delivering nutritional payloads directly to the bodily tissues that need them.